Kyle Clark, serving as President and Chief Executive Officer of BETA Technologies, Inc. (BETA), executed a series of stock sales totaling $810,337 in Class A common equity during mid-July. The divestment occurred across three consecutive days, from July 13 to July 15, 2026, and was facilitated through The Godric’s Hollow Trust, an entity linked to Mr. Clark. These transactions were conducted in accordance with a pre-established 10b5-1 trading plan, a mechanism designed to allow executives to trade shares without appearing to react to material non-public information. Mr. Clark has formally disclaimed beneficial ownership of these securities, limiting his interest to pecuniary rights.
The timing of the sales coincides with BETA Technologies trading at $18.53 per share, a level that represents a 48% decline over the past year. Despite this downward price action, InvestingPro analysis indicates that the company may remain undervalued at current market levels. The specific transactions were executed as follows: on July 13, The Godric’s Hollow Trust sold 15,000 shares at a weighted average price of $17.4793, with individual prices ranging from $17.29 to $17.80. On July 14, another 15,000 shares were disposed of at a weighted average price of $18.1265, with prices between $17.58 and $18.41. The final tranche on July 15 involved 15,000 shares sold at a weighted average price of $18.4167, with transaction prices ranging from $18.11 to $18.69.
Following these sales, Mr. Clark’s direct holdings consist of 748,915 shares of Class A common stock. His indirect ownership includes 49,746 shares held through his spouse, 1,624,907 shares via The Burrow Trust, and 5,494,837 shares through The Godric’s Hollow Trust. Mr. Clark has also disclaimed beneficial ownership of these indirect holdings, except to the extent of his pecuniary interest therein. Despite reporting robust revenue growth of 73%, InvestingPro Tips indicate that the company is not expected to achieve profitability in the current fiscal year.
In operational developments, BETA Technologies continues to engage with the Federal Aviation Administration’s eVTOL Integration Pilot Program. The company successfully completed its inaugural electric aircraft flights, which transported manufactured organs developed by United Therapeutics. These flights are part of a broader initiative that will eventually span at least 26 states. Meanwhile, analyst sentiment shows divergence: Cantor Fitzgerald reiterated an Overweight rating for BETA Technologies, maintaining a price target of $31, while BTIG reduced its price target from $40 to $33 due to revised delivery expectations. In corporate governance, the company held its 2026 Annual Meeting of Stockholders, where shareholders elected John Abele, James McConville, and John Slattery as Class I directors and ratified the independent auditor. Archer Aviation also received attention as Cantor Fitzgerald reiterated an Overweight rating and set a price target of $11, coinciding with the FAA’s announcement of the eVTOL Integration Pilot Program.